Timely selec­tion of the most effec­tive ther­apy saves treat­ment costs, pro­longs life­time of the patient, and improves his/her qual­ity of life !

 

CTC TESTS

The Prognosis, Prediction and Monitoring Tests are based on the mol­e­c­u­lar detec­tion of Cir­cu­lat­ing Tumor Cells (CTCs) as a mea­sure of ther­apy effi­cacy and recur­rence of can­cer. The pres­ence and molecular char­ac­ter­is­tics of CTCs are ana­lyzed by quan­tifi­ca­tion of RNA pan­els spe­cific for each type of cancer.

Our CTC tests pro­vide reli­able information

  • to stop inef­fec­tive treat­ment early on, avoid­ing unnec­es­sary side effects which are a heavy bur­den for the patient;

  • to choose an alter­na­tive, more effec­tive therapy;

  • to detect can­cer relapse ear­lier than any other cur­rently avail­able method, enabling ear­li­est pos­si­ble onset of treatment.

All Prognosis, Prediction and Monitoring Tests are non-​invasive and rely on novel con­cepts ensur­ing unprece­dented sen­si­tiv­i­tiy and speci­ficity. This has already been demon­strated for ovar­ian cancer. These tests will be pro­vided for ovar­ian can­cer, breast can­cer, endome­trial can­cer, cer­vi­cal can­cer, col­orec­tal can­cer, and lung cancer.

OncoLab Diagnostics GmbH 2017
Mahlerstrasse 13
1010 Vienna
Austria